Ropivacaine nerve block for lower extremity clinical study.doc

 PAGE \* MERGEFORMAT 10 Ropivacaine nerve block for lower extremity clinical study [Abstract] Objective To observe the different concentrations of ropivacaine in peripheral nerve stimulator (PNS guided lumbar plexus nerve block and find a lower effective concentration and reduce the possibility of toxicity. Methods 90 patients scheduled for unilateral lower limb surgery were randomly divided into three groups, n = 30, , , groups were guided lumbar plexus PNS sciatic nerve block, ropivacaine concentration was 0.25%, 0.375%, 0.5% and capacity are 55 ml, lumbar plexus block in which 30 ml, sciatic nerve block 25 ml. the results of the three groups followed by the onset time of nerve block is 37.1 + -7.2 min, 25.4 + -4.6 min, 19.3 + -5.5 min (P lt;0.05. group obturator nerve and lateral femoral cutaneous nerve block was significantly higher than in group (P lt;0.05, group of block success rate was significantly higher than in group (P lt;0.05. , group the indicators no significant difference. Conclusions of 0.375% ropivacaine for sciatic nerve block lumbar plexus PNS when the boot block sound while reducing the amount of local anesthetic drugs. [Keywords:] ropivacaine sciatic nerve block lumbar plexus peripheral nerve stimulator Psoas sciatic nerve block anesthesia combined with unilateral lower extremity limb can get the full anesthesia, while avoiding the spinal puncture, a negligible effect on the cycle for unilateral lower limb surgery, especially for spinal anesthesia contraindicated or associated with severe systemic disease patients. peripheral nerve stimulator (PNS advent make this method more convenient, the success rate greatly. but because of lumbar plexus nerve block a larger amount of local anesthetic required, there is the potential toxicity and risks. The effects of low concentrations of ropivacaine block was designed to find the effective low block concentrations, reducing the possibility of toxicity. Materials and Methods 1. Ge